These outcomes are reliable with Those people in a 2022 trial extension on semaglutide (the generic title for Ozempic and Wegovy), which suggested that individuals who stopped taking two.four mg weekly doses regained two-thirds from the weight they dropped within one particular 12 months of cessation. The amount of time it requires for weight loss